Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16926224rdf:typepubmed:Citationlld:pubmed
pubmed-article:16926224lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16926224lifeskim:mentionsumls-concept:C1522449lld:lifeskim
pubmed-article:16926224lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:16926224lifeskim:mentionsumls-concept:C1336219lld:lifeskim
pubmed-article:16926224lifeskim:mentionsumls-concept:C0282460lld:lifeskim
pubmed-article:16926224lifeskim:mentionsumls-concept:C1527392lld:lifeskim
pubmed-article:16926224lifeskim:mentionsumls-concept:C0149256lld:lifeskim
pubmed-article:16926224pubmed:issue9lld:pubmed
pubmed-article:16926224pubmed:dateCreated2006-10-9lld:pubmed
pubmed-article:16926224pubmed:abstractTextTo find the optimal dose of immunomodulator Z-100 in patients with stage IIIB squamous cell carcinoma of the cervix in combination with radiation therapy.lld:pubmed
pubmed-article:16926224pubmed:languageenglld:pubmed
pubmed-article:16926224pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16926224pubmed:citationSubsetIMlld:pubmed
pubmed-article:16926224pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16926224pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16926224pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16926224pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16926224pubmed:statusMEDLINElld:pubmed
pubmed-article:16926224pubmed:monthSeplld:pubmed
pubmed-article:16926224pubmed:issn0368-2811lld:pubmed
pubmed-article:16926224pubmed:authorpubmed-author:OgitaSachioSlld:pubmed
pubmed-article:16926224pubmed:authorpubmed-author:FujiiShingoSlld:pubmed
pubmed-article:16926224pubmed:authorpubmed-author:OhashiYasuoYlld:pubmed
pubmed-article:16926224pubmed:authorpubmed-author:FujiwaraKeiic...lld:pubmed
pubmed-article:16926224pubmed:authorpubmed-author:NiibeHideoHlld:pubmed
pubmed-article:16926224pubmed:authorpubmed-author:MoritaKozoKlld:pubmed
pubmed-article:16926224pubmed:authorpubmed-author:NodaKiichiroKlld:pubmed
pubmed-article:16926224pubmed:authorpubmed-author:KikuchiYuzoYlld:pubmed
pubmed-article:16926224pubmed:authorpubmed-author:OzakiMasamiMlld:pubmed
pubmed-article:16926224pubmed:authorpubmed-author:TakegawaYoshi...lld:pubmed
pubmed-article:16926224pubmed:authorpubmed-author:OkadaHirojiHlld:pubmed
pubmed-article:16926224pubmed:authorpubmed-author:HoriuchiJunic...lld:pubmed
pubmed-article:16926224pubmed:authorpubmed-author:HashimotoShoz...lld:pubmed
pubmed-article:16926224pubmed:issnTypePrintlld:pubmed
pubmed-article:16926224pubmed:volume36lld:pubmed
pubmed-article:16926224pubmed:ownerNLMlld:pubmed
pubmed-article:16926224pubmed:authorsCompleteYlld:pubmed
pubmed-article:16926224pubmed:pagination570-7lld:pubmed
pubmed-article:16926224pubmed:meshHeadingpubmed-meshheading:16926224...lld:pubmed
pubmed-article:16926224pubmed:meshHeadingpubmed-meshheading:16926224...lld:pubmed
pubmed-article:16926224pubmed:meshHeadingpubmed-meshheading:16926224...lld:pubmed
pubmed-article:16926224pubmed:meshHeadingpubmed-meshheading:16926224...lld:pubmed
pubmed-article:16926224pubmed:meshHeadingpubmed-meshheading:16926224...lld:pubmed
pubmed-article:16926224pubmed:meshHeadingpubmed-meshheading:16926224...lld:pubmed
pubmed-article:16926224pubmed:meshHeadingpubmed-meshheading:16926224...lld:pubmed
pubmed-article:16926224pubmed:meshHeadingpubmed-meshheading:16926224...lld:pubmed
pubmed-article:16926224pubmed:meshHeadingpubmed-meshheading:16926224...lld:pubmed
pubmed-article:16926224pubmed:meshHeadingpubmed-meshheading:16926224...lld:pubmed
pubmed-article:16926224pubmed:meshHeadingpubmed-meshheading:16926224...lld:pubmed
pubmed-article:16926224pubmed:meshHeadingpubmed-meshheading:16926224...lld:pubmed
pubmed-article:16926224pubmed:meshHeadingpubmed-meshheading:16926224...lld:pubmed
pubmed-article:16926224pubmed:meshHeadingpubmed-meshheading:16926224...lld:pubmed
pubmed-article:16926224pubmed:meshHeadingpubmed-meshheading:16926224...lld:pubmed
pubmed-article:16926224pubmed:meshHeadingpubmed-meshheading:16926224...lld:pubmed
pubmed-article:16926224pubmed:meshHeadingpubmed-meshheading:16926224...lld:pubmed
pubmed-article:16926224pubmed:meshHeadingpubmed-meshheading:16926224...lld:pubmed
pubmed-article:16926224pubmed:meshHeadingpubmed-meshheading:16926224...lld:pubmed
pubmed-article:16926224pubmed:year2006lld:pubmed
pubmed-article:16926224pubmed:articleTitleRandomized phase II study of immunomodulator Z-100 in patients with stage IIIB cervical cancer with radiation therapy.lld:pubmed
pubmed-article:16926224pubmed:affiliationKinki University, Japan.lld:pubmed
pubmed-article:16926224pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16926224pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:16926224pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:16926224pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:16926224pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed